AstraZeneca: Efficacy of its COVID-19 Vaccine
March 31, 2021
Rejecting sharp criticism from U.S. government scientists, AstraZeneca said March 24th that its Covid-19 vaccine was 76% effective at reducing the risk of symptomatic Covid-19, and 100% effective against severe disease, in a new analysis of its large U.S.-based clinical trial.
Those estimates were just a few percentage points lower than much more sparse results the company released Monday from an earlier analysis of the study, despite dramatic statements from government scientists that AstraZeneca’s initial release may have used “outdated information” that could have been overly favor...
For access to this article please
sign in or
subscribe.
Reader Comments(0)